Under non-pathological conditions, an active Akt phosphorylates GSK-3β at Ser 9 and renders it inactive, making high levels of phosphorylated GSK-3β (P-GSK-3β) indicative for a beneficial effect on AD. This evidence concerns the gene AKT1 and Alzheimer disease.